18.34
price up icon1.10%   0.20
after-market Dopo l'orario di chiusura: 18.34
loading

Dianthus Therapeutics Inc Azioni (DNTH) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-09-30
Durata del periodo 3 mesi 3 mesi
Revenues
5.41%
0.874
0.924
Operating Expenses
12.20%
18.72
16.68
Benefits Costs and Expenses
14.62
-
Costs And Expenses
12.20%
18.72
16.68
Operating Income/Loss
13.23%
-17.84
-15.76
Nonoperating Income/Loss
311.24%
4.096
0.996
Income/Loss From Continuing Operations Before Tax
1,588%
-13.75
0.924
Income/Loss From Continuing Operations After Tax
6.88%
-13.75
-14.76
Net Income/Loss
6.88%
-13.75
-14.76
Preferred Stock Dividends And Other Adjustments
-
-
Attributable To Noncontrolling Interest
-
-
Basic Average Shares
556.93%
25.67
3.9069
Diluted Average Shares
556.93%
25.67
3.9069
Basic Earnings Per Share
85.71%
-0.54
-3.78
Diluted Earnings Per Share
85.71%
-0.54
-3.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
-
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):